Journal of Qualitative Research in Health Sciences

Document Type : Original Article


1 Department of Psychology and Education, Faculty of Humanities, Khatam University, Tehran, Iran

2 Faculty of Nursing and Midwifery, Golestan University of Medical Sciences, Gorgan, Iran



Background: Many studies have shown that psychological distress such as worries and anxiety is one of the causes of the development, recurrence, or exacerbation of multiple sclerosis (MS). This study aimed to explore the lived experiences of patients with MS during the COVID-19 pandemic.
Methods: This qualitative study was conducted using an interpretive phenomenological approach. The participants were selected from patients with MS in Tehran, Iran who were members of the Iranian MS Society in 2021. The research sample included 19 patients with MS who were selected using purposive sampling. The data were collected using semi-structured interviews until the data were saturated. The collected data were analyzed using Van Manen’s phenomenological approach, and the validity and truthfulness of the data were confirmed using the four criteria proposed by Lincoln and Guba.
Results: Explication of the data revealed 22 subthemes and 5 main themes. The main themes identified were: Feeling of helplessness and fear of inadequacy in self-care, Economic concerns and financial problems, Ineffective interaction with family members, preoccupations and obsessions with the pandemic, and ambivalent and conflicting beliefs about others.
Conclusion: The experiences of those affected by the pandemic were linked to personal and familial concerns, health issues, feelings of inadequacy in self-care, and economic difficulties. Additionally, participants were preoccupied with the pandemic and the social problems they faced. Gaining an understanding of these experiences can offer valuable insights to medical professionals, families of patients, and relevant organizations regarding the lived experiences of individuals with MS.


Roozbeh Shirooyeh (Google Scholar) (PubMed)

Anahita Khodabakhshi-Koolaee (Google Scholar) (PubMed)

Leila Jouybari (Google Scholar) (PubMed)


  1. Goldenberg MM. Multiple sclerosis review. P T. 2012;37(3):175-84.
  2. Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816-21. doi: 10.1177/1352458520970841.
  3. Karimi S, Andayeshgar B, Khatony A. Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study. BMC Psychiatry. 2020;20(1):166. doi: 10.1186/s12888-020-02579-z.
  4. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17(5):1729. doi: 10.3390/ ijerph17051729.
  5. Ganesan B, Al-Jumaily A, Fong KNK, Prasad P, Meena SK, Tong RK. Impact of coronavirus disease 2019 (COVID-19) outbreak quarantine, isolation, and lockdown policies on mental health and suicide. Front Psychiatry. 2021;12:565190. doi: 10.3389/fpsyt.2021.565190.
  6. Altınkaynak Yılmaz T, Ozdelikara A. The effect on the anxiety level of the social support given to multiple sclerosis patients. Perspect Psychiatr Care. 2022;58(1):411-7. doi: 10.1111/ ppc.12807.
  7. Tauil CB, Rocha-Lima AD, Ferrari BB, da Silva FM, Machado LA, Ramari C, et al. Depression and anxiety disorders in patients with multiple sclerosis: association with neurodegeneration and neurofilaments. Braz J Med Biol Res. 2021;54(3):e10428. doi: 10.1590/1414-431x202010428.
  8. Kołtuniuk A, Rosińczuk J. The levels of depression, anxiety, acceptance of illness, and medication adherence in patients with multiple sclerosis - descriptive and correlational study. Int J Med Sci. 2021;18(1):216-25. doi: 10.7150/ijms.51172.
  9. Haji Akhoundi F, Sahraian MA, Naser Moghadasi A. Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients. Mult Scler Relat Disord. 2020;41:102164. doi: 10.1016/j.msard.2020.102164.
  10. Stojanov A, Malobabic M, Milosevic V, Stojanov J, Vojinovic S, Stanojevic G, et al. Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak. Mult Scler Relat Disord. 2020;45:102407. doi: 10.1016/j.msard.2020.102407.
  11. Błachut M, Szczegielniak AR, Świerzy K, Zając-Tarska M, Kubicka-Bączyk K, Adamczyk-Sowa M, et al. Prevalence of psychiatric disorders among patients with Multiple Sclerosis: a cross-sectional study. Res Sq [Preprint]. April 30, 2020. Available from: 24149/v1.
  12. Hanna M, Strober LB. Anxiety and depression in multiple sclerosis (MS): antecedents, consequences, and differential impact on well-being and quality of life. Mult Scler Relat Disord. 2020;44:102261. doi: 10.1016/j.msard.2020.102261.
  13. Van Manen M. Researching Lived Experience: Human Science for an Action Sensitive Pedagogy. Routledge; 2016.
  14. Guba EG, Lincoln YS. Competing paradigms in qualitative research. In: Handbook of Qualitative Research. Thousand Oaks: SAGE Publications; 1994. p. 105-17.
  15. Stommel M, Wills C. Clinical Research: Concepts and Principles for Advanced Practice Nurses. Lippincott Williams & Wilkins; 2004.
  16. Barbour RS. Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ. 2001;322(7294):1115-7. doi: 10.1136/bmj.322.7294.1115.
  17. Doyle S. Member checking with older women: a framework for negotiating meaning. Health Care Women Int. 2007;28(10):888-908. doi: 10.1080/07399330701615325.
  18. Streubert HJ, Rinaldi Carpenter D. Qualitative Research in Nursing: Advancing the Humanistic Imperative. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
  19. Holloway I, Wheeler S. Qualitative Research in Nursing. 2nd ed. Oxford: Blackwell Science; 2002.
  20. Powers BA, Knapp TR. Dictionary of Nursing Theory and Research. Springer Publishing Company; 2010.
  21. Seligman M. Flourish: positive psychology and positive interventions. In: The Tanner Lectures on Human Values. University of Michigan; 2010. p. 1-56.
  22. Le Bourg E. Epidemics and forecasts of life expectancy. Gerontology. 2022;68(4):453-5. doi: 10.1159/000517947.
  23. Vasishtha G, Mohanty SK, Mishra US, Dubey M, Sahoo U. Impact of COVID-19 infection on life expectancy, premature mortality, and DALY in Maharashtra, India. BMC Infect Dis. 2021;21(1):343. doi: 10.1186/s12879-021-06026-6.
  24. Aburto JM, Kashyap R, Schöley J, Angus C, Ermisch J, Mills MC, et al. Estimating the burden of the COVID-19 pandemic on mortality, life expectancy and lifespan inequality in England and Wales: a population-level analysis. J Epidemiol Community Health. 2021;75(8):735-40. doi: 10.1136/jech- 2020-215505.
  25. Sadovnick AD, Ebers GC, Wilson RW, Paty DW. Life expectancy in patients attending multiple sclerosis clinics. Neurology. 1992;42(5):991-4. doi: 10.1212/wnl.42.5.991.
  26. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 5th ed. APA; 2013. p. 591-643.
  27. Apelian Soureshgani l, Khodabakhshi-Koolaee A. Analysis of obsessive-compulsive disorder experiences in multiple sclerosis patients: a phenomenological study. Iranian Journal of Psychiatric Nursing. 2021;9(3):1-11. [Persian].
  28. Khodabakhshi-Koolaee A. Living in home quarantine: analyzing psychological experiences of college students during COVID-19 pandemic. J Mil Med. 2022;22(2):130-8. doi: 10.30491/jmm.22.2.130. [Persian].
  29. Costabile T, Carotenuto A, Lavorgna L, Borriello G, Moiola L, Inglese M, et al. COVID-19 pandemic and mental distress in multiple sclerosis: implications for clinical management. Eur J Neurol. 2021;28(10):3375-83. doi: 10.1111/ene.14580.
  30. Pokryszko-Dragan A, Chojdak-Łukasiewicz J, Gruszka E, Pawłowski M, Pawłowski T, Rudkowska-Mytych A, et al. Burden of COVID-19 pandemic perceived by Polish patients with multiple sclerosis. J Clin Med. 2021;10(18):4215. doi: 10.3390/jcm10184215.
  31. Shaygannejad V, Mirmosayyeb O, Nehzat N, Ghajarzadeh M. Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage. Neurol Sci. 2021;42(7):2615-8. doi: 10.1007/s10072-021-05253-8.
  32. Khodabakhshi-Koolaee A, Pourebrahimi M. Analyzes of life world of a young girl with myasthenia gravis: qualitative case study. J Arak Uni Med Sci. 2020;23(3):412-21. doi: 10.32598/ jams.23.3.5888.4. [Persian].
  33. Ciccarelli O, Cohen JA, Thompson A. Response of the multiple sclerosis community to COVID-19. Mult Scler. 2020;26(10):1134-6. doi: 10.1177/1352458520948748.
  34. Khftan P, Vameghi R, Khankeh HR, Fathi M, Arshi M, Gholami Jam F. Exploring therapeutic problems in women with multiple sclerosis: a qualitative study. J Qual Res Health Sci. 2017;6(1):13-21. [Persian].
  35. Ghanbari S, Ghasemzadeh R. Experiences of multiple sclerosis patients about leisure time activities. J Qual Res Health Sci. 2020;1(1):15-26. [Persian].
  36. Wilson BA, Winegardner J, van Heugten CM, Ownsworth T. Neuropsychological Rehabilitation: The International Handbook. Psychology Press; 2017.
  37. Capasso N, Palladino R, Montella E, Pennino F, Lanzillo R, Carotenuto A, et al. Prevalence of SARS-CoV-2 antibodies in multiple sclerosis: the hidden part of the iceberg. J Clin Med. 2020;9(12):4066. doi: 10.3390/jcm9124066.
  38. Mirzaee MS, Salamat A, Mardani-Hamooleh M, Abbasi Z, Salehi T. Nurses’ challenges in caring for patients with COVID-19: a qualitative study. J Qual Res Health Sci. 2022;11(3):189-95. doi: 10.34172/jqr.2022.06.